title: Nanostructure embedded microchips for detection, isolation, and characterization of circulating tumor cells.
abstract: Circulating tumor cells (CTCs) are cancer cells that break away from either a primary tumor or a metastatic site and circulate in the peripheral blood as the cellular origin of metastasis. With their role as a "tumor liquid biopsy", CTCs provide convenient access to all disease sites, including that of the primary tumor and the site of fatal metastases. It is conceivable that detecting and analyzing CTCs will provide insightful information in assessing the disease status without the flaws and limitations encountered in performing conventional tumor biopsies. However, identifying CTCs in patient blood samples is technically challenging due to the extremely low abundance of CTCs among a large number of hematologic cells. To address this unmet need, there have been significant research endeavors, especially in the fields of chemistry, materials science, and bioengineering, devoted to developing CTC detection, isolation, and characterization technologies. Inspired by the nanoscale interactions observed in the tissue microenvironment, our research team at UCLA pioneered a unique concept of "NanoVelcro" cell-affinity substrates, in which CTC capture agent-coated nanostructured substrates were utilized to immobilize CTCs with high efficiency. The working mechanism of NanoVelcro cell-affinity substrates mimics that of Velcro: when the two fabric strips of a Velcro fastener are pressed together, tangling between the hairy surfaces on two strips leads to strong binding. Through continuous evolution, three generations (gens) of NanoVelcro CTC chips have been established to achieve different clinical utilities. The first-gen NanoVelcro chip, composed of a silicon nanowire substrate (SiNS) and an overlaid microfluidic chaotic mixer, was created for CTC enumeration. Side-by-side analytical validation studies using clinical blood samples suggested that the sensitivity of first-gen NanoVelcro chip outperforms that of FDA-approved CellSearch. In conjunction with the use of the laser microdissection (LMD) technique, second-gen NanoVelcro chips (i.e., NanoVelcro-LMD), based on polymer nanosubstrates, were developed for single-CTC isolation. The individually isolated CTCs can be subjected to single-CTC genotyping (e.g., Sanger sequencing and next-generation sequencing, NGS) to verify the CTC's role as tumor liquid biopsy. Created by grafting of thermoresponsive polymer brushes onto SiNS, third-gen NanoVelcro chips (i.e., Thermoresponsive NanoVelcro) have demonstrated the capture and release of CTCs at 37 and 4 °C, respectively. The temperature-dependent conformational changes of polymer brushes can effectively alter the accessibility of the capture agent on SiNS, allowing for rapid CTC purification with desired viability and molecular integrity. This Account summarizes the continuous evolution of NanoVelcro CTC assays from the emergence of the original idea all the way to their applications in cancer research. We envision that NanoVelcro CTC assays will lead the way for powerful and cost-efficient diagnostic platforms for researchers to better understand underlying disease mechanisms and for physicians to monitor real-time disease progression.
authors.affiliation: Department of Pathology, The First Affiliated hospital of Sun Yat-sen University , Guangzhou, 510080 Guangdong, People's Republic of China.
authors.forename: Millicent
authors.initials: M
authors.lastname: Lin
authors.forename: Jie-Fu
authors.initials: JF
authors.lastname: Chen
authors.forename: Yi-Tsung
authors.initials: YT
authors.lastname: Lu
authors.forename: Yang
authors.initials: Y
authors.lastname: Zhang
authors.forename: Jinzhao
authors.initials: J
authors.lastname: Song
authors.forename: Shuang
authors.initials: S
authors.lastname: Hou
authors.forename: Zunfu
authors.initials: Z
authors.lastname: Ke
authors.forename: Hsian-Rong
authors.initials: HR
authors.lastname: Tseng
mesh_terms: D002469:Cell Separation / Q000295:instrumentation / Q000379:methods*; D006801:Humans; D046210:Microfluidic Analytical Techniques / Q000295:instrumentation / Q000379:methods*; D049329:Nanostructures / Q000737:chemistry*; D009360:Neoplastic Cells, Circulating / Q000473:pathology*
references.citation: N Engl J Med. 2004 Aug 19;351(8):781-91
references.pmid: 15317891
references.citation: Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3970-5
references.pmid: 19234122
references.citation: Adv Mater. 2012 May 22;24(20):2756-60
references.pmid: 22528884
references.citation: ACS Nano. 2013 Jan 22;7(1):566-75
references.pmid: 23194329
references.citation: Nature. 2007 Dec 20;450(7173):1235-9
references.pmid: 18097410
references.citation: Chem Soc Rev. 2013 Jan 7;42(1):225-62
references.pmid: 22990473
references.citation: Acc Chem Res. 2010 Jan 19;43(1):48-57
references.pmid: 19751057
references.citation: Curr Opin Oncol. 2010 Nov;22(6):552-8
references.pmid: 20706122
references.citation: Lab Chip. 2013 Feb 7;13(3):391-6
references.pmid: 23223939
references.citation: Adv Mater. 2011 Nov 2;23(41):4788-92
references.pmid: 21954025
references.citation: Adv Mater. 2013 Apr 24;25(16):2368-73
references.pmid: 23495071
references.citation: Biomed Microdevices. 2009 Aug;11(4):883-92
references.pmid: 19387837
references.citation: Clin Cancer Res. 2007 Apr 1;13(7):2023-9
references.pmid: 17404082
references.citation: Angew Chem Int Ed Engl. 2009;48(47):8970-3
references.pmid: 19847834
references.citation: Biomaterials. 1995 Mar;16(4):297-303
references.pmid: 7772669
references.citation: Chem Soc Rev. 2014 Apr 21;43(8):2385-401
references.pmid: 24504119
references.citation: Science. 2010 Feb 26;327(5969):1072-4
references.pmid: 20185704
references.citation: Biosens Bioelectron. 2012 May 15;35(1):167-173
references.pmid: 22429961
references.citation: Lab Chip. 2014 Jan 7;14(1):12-3
references.pmid: 24247213
references.citation: Small. 2012 Jun 11;8(11):1657-63
references.pmid: 22434693
references.citation: Angew Chem Int Ed Engl. 2011 Mar 21;50(13):3084-8
references.pmid: 21374764
references.citation: Nano Lett. 2009 Feb;9(2):716-20
references.pmid: 19199759
references.citation: Adv Mater. 2013 Jun 4;25(21):2897-902
references.pmid: 23529932
references.citation: Small. 2014 Aug 13;10(15):3012-7
references.pmid: 24700425
references.citation: Angew Chem Int Ed Engl. 2009;48(30):5406-15
references.pmid: 19492373
references.citation: Anal Chem. 2013 Feb 19;85(4):2465-71
references.pmid: 23387387
references.citation: Adv Mater. 2013 Mar 20;25(11):1547-51
references.pmid: 23255101
references.citation: Biomed Microdevices. 2013 Aug;15(4):617-626
references.pmid: 23780622
references.citation: Transl Oncol. 2013 Oct 01;6(5):528-38
references.pmid: 24151533
references.citation: Adv Mater. 2013 Jul 12;25(26):3566-70
references.pmid: 23716475
references.citation: Science. 2014 Jul 11;345(6193):216-20
references.pmid: 25013076
references.citation: J Am Chem Soc. 2008 Jul 9;130(27):8633-41
references.pmid: 18557614
references.citation: Angew Chem Int Ed Engl. 2013 Mar 18;52(12):3379-83
references.pmid: 23436302
references.citation: Cancer Res. 2010 Aug 1;70(15):6128-38
references.pmid: 20631065
references.citation: Proc Natl Acad Sci U S A. 2007 Jul 10;104(28):11760-5
references.pmid: 17601776
references.citation: Nano Lett. 2012 Mar 14;12(3):1638-42
references.pmid: 22364234
references.citation: Nat Biotechnol. 2014 May;32(5):479-84
references.pmid: 24752078
references.citation: Methods. 2013 Dec 1;64(2):144-52
references.pmid: 23816790
references.citation: Science. 2002 Jan 25;295(5555):647-51
references.pmid: 11809963
references.citation: Cancer Res. 2011 Sep 15;71(18):5955-60
references.pmid: 21896640
references.citation: Br J Cancer. 2011 Oct 25;105(9):1338-41
references.pmid: 21970878
references.citation: ACS Nano. 2011 Jul 26;5(7):5444-56
references.pmid: 21702475
references.citation: Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18392-7
references.pmid: 20930119
references.citation: Nat Rev Cancer. 2008 May;8(5):329-40
references.pmid: 18404148
references.citation: Sci Transl Med. 2013 Apr 3;5(179):179ra47
references.pmid: 23552373